GetTopicDetailResponse(id=b46f1921993, topicName=β3-腎上腺素能受體拮抗劑, introduction=β3-腎上腺素能受體拮抗劑, content=null, image=null, comments=1, allHits=969, url=https://h5.medsci.cn/topic?id=19219, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=98879, tagList=[TagDto(tagId=98879, tagName=β3-腎上腺素能受體拮抗劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2043660, encodeId=0f95204366083, content=<a href='/topic/show?id=b46f1921993' target=_blank style='color:#2F92EE;'>#β3-腎上腺素能受體拮抗劑#</a>, objectTitle=FDA授予β3-腎上腺素能受體拮抗劑APD418用于代償性心力衰竭治療的快速通道指定, objectType=article, longId=186459, objectId=09c218645948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09c218645948, replyNumber=0, likeNumber=99, createdTime=2020-06-13, rootId=0, userName=wgx306, userId=4193478, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09c218645948, moduleTitle=FDA授予β3-腎上腺素能受體拮抗劑APD418用于代償性心力衰竭治療的快速通道指定, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=09c218645948)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
